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Abstract 
Background: 
Asthma is common in both children and adults in the Western world, just like anxiety and 
depression. While some research has revealed that these diseases might share important 
environmental and pathophysiological aspects, the exact mechanisms still remain unclear.  
Objective: 
To study the correlation firstly between depression or anxiety and asthma diagnosis in adult 
twins, and secondly the association between parental depression or anxiety and offspring 
asthma in children of twins. 
Methods: 
In total, 24,685 adult twins aged 20-47 years were interviewed or completed a web-based 
questionnaire and their children were identified through the Multi-Generation Register. 
Asthma diagnosis was obtained from the Patient Register and the Prescribed Drug Register. 
Assessment of depression and anxiety was obtained from questionnaires using Center for 
Epidemiologic Studies Depression Scale (CES-D), Major Depression and Generalized 
Anxiety Disorder (GAD) from DSM-IV. The association between depression or anxiety and 
asthma was analyzed with logistic regression adjusting for confounders in twins and 
offspring. To address genetic and familial environmental confounding we performed a co-
twin analysis using disease-discordant twin pairs. 
Results: 
We found an association between asthma and CES-D, major depression and GAD, e.g. 
adjusted OR for major depression and register-based asthma 1.56(1.36-1.79). Most of the 
point estimates remained in the co-twin control analysis, indicating that the association was 
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likely not due to genetic or familial environmental factors.  There was no association between 
parental depression and/or anxiety and asthma diagnosis in the offspring which implies lack 
of genetic confounding. 
Conclusions: 
We found an association between own asthma diagnosis and anxiety or depression, but not 
with offspring asthma. Our results indicate that the associations were not due to confounding 
from genes or environment shared by the twins.  
 
Keywords 
CESD, Childhood asthma, Generalized anxiety, Major depression, Offspring asthma, Twin 
study 
Abbreviations 
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CES-D  Center for Epidemiologic Studies Depression Scale  
CI  confidence interval 
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LISA  The Longitudinal integration database for health insurance and labor market 
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MBR  Medical Birth Register 
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Introduction 
 
The prevalence of asthma among both adults and children is high in many 
countries around the world [1, 2]. Depression is also a common disease [3] and several studies 
have found a correlation between asthma and depression [4-7] [8].  Anxiety disorders with 
generalized anxiety (GAD) defined as an excessive worry and anxiety [9] is common as well 
and as reviewed  by ten Thoren et al there is a higher incidence of anxiety disorders in 
asthmatic patients [10]. The association between asthma and depression/anxiety is not clearly 
understood even though several studies have been performed. As reviewed by Di Marco 
emerging evidence that the diseases share similar environmental and pathophysiological 
mechanisms suggest interactions between behavioral, neural, endocrine and immune 
processes [11]. 
Previous studies on the association between parental depression or anxiety and 
asthma in offspring have found higher risk of asthma in children in relation to prenatal 
maternal stress [12-14], maternal stress reported during the child’s first year of life [15, 16] 
and parental depression [17, 18]. Moreover, children exposed to maternal stress during 
pregnancy  or postpartum had an increased risk for wheezing, but children exposed during 
both periods showed a threefold increase in odds of infant wheeze, suggesting that  a more 
prolonged period of maternal distress is even more likely to increase the risk of childhood 
wheeze [19]. We have recently reported from a nationwide population-based study that boys 
born to mothers with loss of an older child during the second trimester had 50% higher risk of 
asthma event at both 1-4 years and 7-12 years [20].  
Genetic and environmental effects may play an important role in the association 
between depression or anxiety and offspring asthma, and have not yet been thoroughly 
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studied. The understanding of the influence of genes and familial environment for an 
association can be improved by using twin design. In a co-twin control design you use the co-
twin of an affected twin as a control. Thereby you can adjust your estimates for confounding 
factors that the twins share, including factors that are unmeasured or even unmeasurable, e.g. 
genes and childhood environment. Stratification by zygosity may give further insight with 
regard to the relative importance of confounding by genes and family environment, since 
dizygotic twins share 50% of their segregating genes and monozygotic 100%.   
We have previously studied adult twins and their spouses and adolescent 
children, and found some association between self-reported maternal anxiety and subjectively 
reported offspring asthma or breathlessness which may be due to familial effects [21]. This 
can be further studied in a population of adult twins and their children where a co-twin control 
design may help differentiate between environmental and genetic confounding of an 
association between depression or anxiety and offspring asthma. 
To better understand if depression and/or anxiety could be causally associated 
with asthma in adults, we aimed to study the association between anxiety or depression and 
asthma diagnosis with adjustment for identified confounders. Further we also aimed to study 
the association between parental depression and/or anxiety and current or subsequent 
childhood asthma in the offspring and address genetic and shared environmental confounding 
using co-twin controls.   
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Methods 
Study design and study population 
The Study of Twin Adults: Genes and Environment (STAGE) study population 
was derived from the Swedish Twin Registry (STR). During 2005-2006 twins born 1959-
1985 were invited to participate in an extensive  telephone interview or web-based 
questionnaire on habits, diseases, diet, living conditions, work etc. to assess the impact of 
gene and environment on future development of different diseases [22]. The National Board 
of Health and Welfare holds several registers with information about demography and health. 
In the Swedish Prescribed Drug register (SPDR) all prescribed drugs dispensed at Swedish 
pharmacies since July 1, 2005 are included. The Patient Register (PAR) covers all public, in-
patient care in Sweden from 1987 and onwards. In 2001 an out-patient part was included 
which covers approximate 75 % of the out-patients visits. The majority of Swedish children 
with asthma are followed by pediatricians in out-patient clinics. The Medical Birth Register 
(MBR) covers data on >98 % of all births in Sweden. The Personal Identity Number (PIN), 
unique for each resident, allows unambiguous linkage between these registers and registers 
held by Statistic Sweden such as the Multi-Generation Register (MGR) with links between 
parent and child and the Longitudinal integration database for health insurance and labor 
market studies (LISA by Swedish acronym) with data on integrating labor market, social 
sector, as well as educational data for all inhabitants 16 years or older with annual updates.  
To derive our study population, firstly twins included in STAGE were defined 
as our twin cohort. Secondly they were linked to the MGR to identify those that were parents.  
Thirdly their children were identified from the MBR and defined as our offspring cohort.  
Additional data on the twins and their children was collected from the MBR and LISA and 
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subsequent development of childhood asthma obtained from the PAR (asthma diagnosis) and 
SPDR (asthma medication).  
Adopted children were excluded. Twins who moved out of the country after the 
questionnaire was answered were also excluded. Twins that could not be linked between the 
registers were also excluded from further analyses.  
 
Variables 
 Parental depression or anxiety was assessed using self-reported scales for 
depression and anxiety included in the STAGE questionnaire.  
 Depression was defined with two different scales, firstly through the Center for 
Epidemiologic Studies Depression Scale (CES-D), an index of self-reported depressive 
symptoms in the last week. Originally developed by Radloff in 1977, the 20 item scale was 
considered to be too long and therefore short versions are more frequently used. We used the 
eleven-item Iowa short version, validated by Kohout [23]. Each item can give a score of 0-3 
points, maximum total 33 points. A score larger than 8 was classified as a possible mild to 
moderate depression and a score equal or more than 12 was regarded as a possible major 
depression. We allowed two missing items, and the score of these two items were calculated 
using imputation of the mean of the individual’s response to the non-missing items of the 
scale. If an individual’s response had more than two missing items the score was set to 
missing. Secondly with the DSM-IV criteria for Major Depression where the specific 
symptoms of depression (such as depressed mood (feels empty, sad, hopeless, tearful), sleep 
disturbance (insomnia/hypersomnia), markedly diminished interest or pleasure from almost 
every activity, significant weight change (up/down) or change of appetite 
(increased/decreased), feeling inhibited or agitated, feeling of lack of energy, feeling of guilt 
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or worthlessness, diminished ability to concentrate, recurrent thoughts about death or suicide) 
were evaluated [24, 25]. To get a positive score at least 5 of the symptoms (at least one of 
depressed mood or loss of interest or pleasure) must have been present during at least two 
weeks, during most of the day every day and caused a significant impact of the patient’s daily 
life. The symptoms should not be attributable to grief, abuse of drugs, medication or other 
somatic disease or injury and caused clinically significant distress or impairment in social, 
occupational or other important areas of functioning.  
General Anxiety Disorder (GAD) according to DSM-IV criteria [24, 25]  was 
categorized as positive when the symptoms of excessive anxiety and worry for specific 
situations or activities, which were difficult to control, were present during most of the day, 
almost every day in the last 6 months.  In addition to this the patient had three or more of the 
following symptoms: feeling restless or on edge, easily get fatigued, difficulty concentrating 
or mind going blank, irritability, muscle tension, and sleep disturbance (difficulty falling or 
staying asleep or restless unsatisfying sleep). The anxiety, worry or physical symptoms 
caused clinically significant distress or impairment in social, occupational or other important 
areas of functioning and were not attributable to grief, abuse of drugs, medication or other 
somatic disease or injury.  
 
Outcomes  
Register-based asthma in the adult twins was derived from the PAR and defined 
if ICD code: J45 and J46 as a primary or secondary diagnosis) and/or prescription of asthma 
drugs in the SPDR, defined as either: 1) any asthma medication except β2- agonist dispensed 
at least twice, or 2) any asthma medication dispensed at least three times during one calendar 
year 2006-2010, identified with the Anatomical Therapeutic Chemical (ATC) codes R03BA 
(inhaled corticosteroids), R03AK (fixed combinations of β2-agonist and corticosteroids), 
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R03DC (leukotriene receptor antagonists) or R03AC (β2- agonist). Dispensed asthma 
medication from the SPDR and register based asthma diagnoses in PAR are suitable proxies 
for asthma diagnosis, according to a recently published validation study by Örtqvist et al [26]. 
Self-reported asthma was obtained from the STAGE questionnaire, defined if 
the question “do you have asthma?” was yes, and clarified further with current or previous 
symptoms, thus as in “asthma ever”.  By the usage of two different variables we created an 
objective diagnosis that occurred after the STAGE questionnaire was answered as well as a 
more subjective one that occurred previously. We were also able to define a larger number of 
asthma cases, including those with a mild asthma. 
The ICD codes are applied related to a diagnosis given either at hospital or 
emergency facilities but also in out-patient specialist clinics. 
In the offspring younger than 4.5 years of age, childhood asthma was derived 
from the PAR and defined if ICD code: J45 and J46 as a primary or secondary diagnosis and 
prescription of asthma drugs in the SPDR, defined as either: 1) any asthma medication except 
β2- agonist dispensed at least twice with at least two weeks between distributions, or 2) any 
asthma medication dispensed at least three times during one calendar year 2006-2010, 
identified with the Anatomical Therapeutic Chemical (ATC) codes R03BA, R03AK, R03DC 
and R03AC. We used this definition to avoid misclassification of asthma in younger children 
with obstructive bronchiolitis due to respiratory infections. 
For children > 4.5 years childhood asthma was defined according to the adult 
definition above.  
Covariates 
Covariates were collected from STR (twin age, gender, zygosity), the STAGE 
questionnaire (smoking and BMI), the MBR (child birth weight, age and gender), and from 
11 
 
LISA (educational level) and categorized as follows: parental age  at the time of questionnaire 
(19-25, 26-30, 31-35, 36-40, 41-45, >46), gender (Male/Female), BMI (<18,5, 18.5-24,9, 25-
29,9, >30 kg/m
2 
or missing), smoking (yes, no or missing) and  educational level; middle 
school 9 years or shorter, high school 3 years or shorter, college studies shorter than 3 years, 
college graduates or higher education or missing), and child age at the time of questionnaire 
(0-4.5, >4.5-12, >12-18, >18). 
 
Statistical analysis 
Firstly, logistic regression was used to estimate odds ratios (OR) with 95% 
confidence intervals (CIs) for the association between anxiety/depression and own asthma 
diagnosis. Crude estimates are reported together with estimates adjusted for age, gender, bmi 
and educational level while using robust standard errors to account for clustering of 
observations within twin pairs.  
Secondly, for the association between parental anxiety or depression and 
offspring asthma we estimated ORs adjusted for age of child, parental educational level, 
parental smoking, parental asthma and parental gender while using robust standard errors to 
account for clustering of observations within families.  
We studied possible effect modification by parental gender by testing for 
interaction with parental depression or anxiety and offspring asthma using likelihood ratio 
test. 
Co-twin controls was used to estimate the association between depression or 
anxiety and asthma when controlling for genetic (100% for MZ and 50% for DZ) and family 
environmental effects. We used conditional logistic regression to estimate ORs among twins 
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discordant for both exposure and outcome and we adjusted for BMI and educational level. 
Twins with unknown zygosity were excluded from these analyses. 
Statistical analyses were conducted using Stata release12.1 (Stata Corp, College 
Station, TX, USA). . 
Permission for the study was obtained from the Regional Ethical Review board in Stockholm, 
Sweden. 
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Results 
 
 In total, 25,383 twins (59.6%) responded to the questionnaire. Register data was 
available for 24,685 twins, 44.2 % of them were male and 15,720 had 32,561 biological 
children, according to the registers. 
Table 1 displays background characteristics of the twins.  The prevalence of 
BMI >30 kg/m
2
 was 5.1 % and 22.0 % were overweight with BMI 25-29, 9. Those with the 
lowest level of education had the highest incidence of asthma. The prevalence of mild to 
moderate CESD was 13.4% and major CESD reported by 16.6%. In total, 3964 twins (16.1%) 
filled the criteria for Major Depression, for GAD the number was 950 (3.8%). The prevalence 
of register-based asthma defined from asthma medication in the Prescribed Drug Register 
and/or diagnose in the Patient Registry was 5.9% in twins. The prevalence of self-reported 
asthma in the questionnaire was 9.8%. 
Table 2 displays general characteristics of the children of the twins. The 
prevalence of register based childhood asthma was 6.7 %. 
 Table 3 displays the associations between depression or anxiety and asthma 
diagnosis in the adult twins. There was a significant association between most measures of 
depression or anxiety and register-based or self-reported asthma outcomes. For example, there 
was an association between major CESD and register-based asthma that remained after 
adjusting for potentially confounding factors, adjusted OR 1.42(95% CI 1.23-1.64) and 
similarly for self-reported asthma. There was also an increased risk of register-based asthma 
diagnosis in twins with major depression, adjusted OR 1.56 (95% CI 1.36-1.79) and was 
stable also for self-reported asthma. In the group of twins with GAD, we found an even higher 
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risk of register based asthma compared to twins without GAD, adjusted OR 1.73 (95 % CI 
1.37-2.19), and this was also similar in the group with self-reported asthma.  
 Table 4 displays the association between parental depression or anxiety in the 
twins and asthma in their children. There was no association between any measures of 
depression or anxiety in the adult twins and register-based asthma in their children. For 
example, children of parents with mild to moderate CES-D did not have an increased risk of 
asthma, adjusted OR 1.03 (95% CI 0.90-1.18). The results were similar for parents with major 
depression as well for those with GAD diagnosis. We also performed a sub analysis in this 
group with children age 0-6 and age 11-22 years old, with similar estimates. For the studied 
associations, there was no effect modification by parental sex.  
The result of the co-twin control analysis for the association between asthma 
diagnosis and depression or anxiety in the adult twins is displayed in table 5. In general, point 
estimates found in cohort analyses remained in the co-twin analyses although with broad 
confidence intervals and mostly not statistically significant.  
For register-based asthma, (n=530 twin pairs) the association between major 
CESD and asthma after adjustment for confounders was OR 1.20 (0.87-1.65). There was an 
association between major depression and asthma that remained after adjusting for all 
confounders, adjusted OR 1.97 (95% CI 1.41-2.76). When stratifying by zygosity there was 
no significant difference in ORs between MZ and DZ. There was a significant association 
between parental GAD and register-based asthma, crude OR 1.71 (1.00-2.93) but this result 
did not remain significant after adjusting for measured confounders. 
For self-reported asthma (n=666 twin pairs), there was an association between 
major CESD and asthma in MZ + DZ twins, which remained significant after adjusting for 
confounders, adjusted OR 1.44( 95% CI 1.10-1.89). When stratifying on zygosity the 
association only remained in the group with DZ twins, with an adjusted OR 2.01 (95% CI 
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1.21-3.35). However, the difference between MZ and DZ pairs was not statistically 
significant. There was an association between major depression and asthma outcomes, crude 
OR 1.28 (95 % CI 1.00-1.62) but this did not remain significant after adjusting for 
confounders, and for GAD we found no statistically significant association with self-reported 
asthma.  
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Discussion 
We found a clear association between depression or anxiety and asthma in 
twins, and this result remained significant after adjusting for confounding factors. The point 
estimates remained in the co-twin analyses, which indicates that the association was not due 
to confounding from genes or shared environmental factors. There was no association 
between parental depression and/or anxiety and asthma diagnosis in the offspring which along 
with the co-twin analysis implies lack of genetic confounding.  
Our finding that there is an association between depression and asthma and 
between anxiety and asthma is in line with previous studies [4-7],[10] [27, 28].  As reviewed 
by Di Marco et al [11] this correlation has been confirmed in a large cross-sectional 
worldwide study and present research is focusing on the interaction between emotional stress, 
the immune system and the hypothalamic–pituitary–adrenocortical (HPA) and sympathetic–
adrenal–medullary (SAM) axes. 
We did not find a correlation between parental depression and/or anxiety and 
offspring asthma. Since previous studies have shown conflicting results it’s possible that it 
depends on the selection of cohort, age groups [15-19, 29] as well as a difference in how 
offspring asthma diagnosis was determined. Kozyrzkyj et al followed a birth cohort of 
children until the age of 7, and found that continued exposure to maternal distress was 
associated with higher incidence of childhood asthma OR 1.25 (95 % CI 1.01-1.55) [15]. 
They defined childhood asthma as two physician visits for asthma, one hospitalization, or two 
prescriptions for any asthma medication (incl. b-2 agonist, inhaled corticosteroids, 
leukotrienes or chromons) at the year of 7. Maternal distress was defined as physicians’ visits, 
hospitalization or prescribed medication for anxiety or depression. Some cohorts only 
followed children during infancy (until 2 and 3 years of age) which is when transient wheeze 
is more common than asthma diagnose [16, 17, 19]. Some studies used questionnaires about 
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asthma diagnose filled by parents themselves [16, 19] which might lead to a subjective 
diagnose rather than objective. 
We have previously shown an association between maternal anxiety and 
subjectively reported offspring asthma but not with register-based offspring asthma diagnosis 
or medication [21], which is in line with our results in this study. Some previous studies are 
made solely on women or on pregnant women [12-14]. Like our study most studies have used 
self-reported questionnaires to estimate level of parental stress/distress/anxiety and this could 
lead to problems with classification of exposure, both in terms of over- and underestimating 
the presence of anxiety or depression. Different scales were used in different cohort which 
also makes it hard to compare. 
More women than men suffer from major depression, as previous research also 
have found [3, 30-32]. More women also suffer from general anxiety disorder GAD, which 
also confirms previous results [30]. One of few studies taking both parents in account was 
Lange et al who studied if maternal and paternal psychosocial stress respectively was 
associated with childhood asthma in a cohort of Puerto Rican twins and found some evidence 
of a correlation with both maternal and paternal stress [17] at age 1. However at age 3 years 
this correlation disappeared for the fathers but remained for maternal stress. In this study the 
offspring asthma diagnosis was not register based, only subjectively reported by parents.  
Our association between depression or anxiety and asthma in twins remained in 
the co-twin analyses, which indicates that it most likely is causal or due to non-shared 
environmental factors such as medication, smoking habits, exposure to high levels of air 
pollution or other diseases. There was no association between parental depression and/or 
anxiety and asthma diagnosis in the offspring which along with the co-twin analysis implies 
absence of genetic confounding.  
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Strengths and limitations 
Strengths 
Firstly, we used a large cohort which results in enough power in the main 
analysis and well validated scales helping minimizing the level of misclassification of 
exposure.  
Secondly,  due to the usage of register data from PAR and SPDR, we defined a 
diagnosis of asthma that was obtained after the questionnaire was filled, and we got an 
objective asthma diagnosis since dispensed asthma medication from the SPDR and register 
based asthma diagnoses in PAR have high positive predicted values as proxies for asthma 
diagnosis [26]. We could however miss some of those who were sick but didn’t seek care, 
those who got a diagnosis but got the wrong one, those who had a mild asthma that did not 
need referral to specialist care or did not need any medication or those who were prescribed 
medications but did not collect them at the pharmacy or not often enough. The self-reported 
asthma from STAGE answers to asthma ever and is likely to include at least some of those not 
captured in the registers; a phenomenon which could be reflected by the higher prevalence of 
self-reported asthma from STAGE was compared to register-based asthma. 
 Thirdly we accounted for several important confounding factors such as 
parental asthma, age, gender as well as smoking, leading to a good level of internal validity. 
Register-based information about educational level minimizes recall bias.  
Fourthly, we performed a twin study including a co-twin control analysis and 
also studied offspring data. Studying several generations help to provide pieces to the puzzle 
on disease development.   
Limitations 
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Not all invited twins responded in this cohort, possibly due to the fact that the 
STAGE questionnaire was extensive, and also contained many questions of sensitive 
character, which might lead to less answers that are true or loss of answers. There is also a 
risk of differential ascertainment such that a twin with depression/anxiety could be more 
likely to receive asthma diagnosis than a twin without depression. Such misclassification 
could lead to overestimation of the association between asthma and depression. 
Non-responders were more often male, from a lower educational level, had at 
least one parent born abroad or had been admitted for psychiatric disorders to a higher degree 
than responders. We lack information on asthma status in the non-responders. However, 
unless the differences between responders and non-responders are large with regard to both 
diseases, we would not expect large biases in the associations [33].  
In the co-twin analysis, numbers were small which gave us low power, in 
particular for detecting differences in associations between MZ and DZ twins. 
Self-reported data about depression and/ or anxiety might lead to 
misclassification of exposure, even though the scales in the questionnaire had high validity. 
Physician diagnosis of depression or GAD would of course be optimal. In PAR data from 
primary health care facilities are not included, which is where many patients with 
mild/moderate asthma normally would seek help. They would however be found in the SPDR 
if they used enough medication so this should not affect the result [26].  
Asthma is a chronic disease causing breathlessness and one could argue that 
depression/anxiety could be a response to that. Depressive symptoms are also described as a 
possible side effect of inhaled corticosteroid treatment, however we found stable estimates 
related to all asthma outcomes regardless of medication. Furthermore, we could not establish 
the temporal sequence of the phenotypes asthma and depression/anxiety. Nor did we have 
information about atopic asthma. We could not thoroughly account for both parents since we 
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had information only about one of them and, as always, residual confounding can not be ruled 
out. 
 
Generalizability 
Generalizability regarding twin studies can be argued, but as indicated in recent 
studies twins [34] [35] [36]  higher risk of asthma compared to singletons appears to be due to 
lower gestational age and birth weight.  
 
Future studies 
A new study with information about the mother before and during pregnancy, 
followed by annual questionnaires for both parents as well as bio samples like saliva-cortisol 
from both parents and child, use of registers for information about birth data, siblings, 
socioeconomic status, asthma diagnose as well as  depression/ anxiety could lead to new 
insights. 
 
Conclusions 
We found a significant correlation between own asthma and GAD and major 
depression, and most point estimates remained when using co-twin controls. This indicates 
that the association could not be explained by familial environment and genes shared by 
twins. We did not find a correlation between parental depression and/or anxiety and offspring 
asthma. 
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Figure 1 Flow chart of the cohort  
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Table  1: General information of STAGE twins 
 Total, N (%)  Register-based Asthma, N (%)  Self-reported Asthma, N (%)   
   No Yes  No Yes Missing  
Age          
19-25 3171 (12.8)  3019 (13.0) 152 (10.4)  2305 (12.3) 361 (15.0) 505 (15.0)  
26-30 4383 (17.8)  4136 (17.8) 247 (16.7)  3194 (17.1) 504 (20.9) 685 (220.4)  
31-35 4396 (17.8)  4157 (17.9) 239 (16.3)  3358 (17.9) 413 (17.1) 625 (18.6)  
36-40 4672 (18.9)  4370 (18.8) 302 (20.6)  3576 (19.1) 440 (18.3) 656 (19.5)  
41-45 5263 (21.3)  4942 (21.3) 321 (21.9)  4097 (21.9) 462 (19.2) 704(21.0)  
>46 2800 (11.3)  2596 (11.2) 204 (13.9)  2192 (11.7) 229 (9.5) 379 (11.3)  
Gender          
Male 10905 (44,2)  10410 (44.8) 495 (31.0)  8239 (44.0) 974 (40.4) 1692 (47.6)  
Female 13780 (55,8)  12810 (33.8) 970 (66.2)  10483 (56.0) 1435 (59.6) 1862 (52.4)  
BMI          
<18.5 577 (2.3)  543 (2.3) 34 (2.3)  477 (2.5) 44 (1.8) 56 (1.6)  
18.5-24.9 15164 (61.4)  14367 (61.9) 797 54.4)  12229 (65.3) 1464 (60.8) 1471 (41.4)  
25-29.9 5433 (22.0)  5097 (21.9) 336 (22.9)  4387 (23.4) 584 (24.2) 462 (13.0)  
>30 1272 (5.1)  1111 (4.8) 161 (11.0)  954 (5.1) 199 (8.3) 119 (3.3)  
Missing 2239 (9.1)  2102 (9.0) 137 (9.3)  675 (3.6) 118 (4.9) 1446 (40.7)  
Smoking           
Non smokers 18435 (74.7)  17409 (75.0) 1026 (70.0)  14254 (76.1) 1780 (73.9) 2401 (67.5)  
Regular smokers 
1
 5321 (21.6)  4941 (21.3) 380 (25.9)  4028 (21.5) 561 (23.3) 732 (20.6)  
Missing 929 (3.8)  870 (3.7) 59 (4.0)  440 (2.3) 68 (2.8) 421 (11.8)  
Education Sun 2000 Level          
Middle school 1495 (6.1)  1386 (6.0) 109 (7.4)  1086 (5.8) 168 (7.0) 241 (7.2)  
High school  11964 (48.5)  11249 (48.4) 715 (48.8)  9012 (48.1) 1202 (49.9) 1750 (52.2)  
College < 3 years 4469 (18.1)  4210 (18.1) 259 (17.7)  3416 (18.2) 435 (18.0) 618 (18.4)  
College graduates/higher education > 3 years 
2
 6487 (26.3)  6115 (26.3) 372 (25.4)  5015 (26.8) 576 (23.9) 896 (26.7)  
Missing 270 (1.1)  260 (1.1) 10 (0.7)  193 (1.0) 28 (1.2) 49 (1.5)  
CES-D          
No 14181 (57.4)  13423 (57.8) 758 (51.7)  12312 (65.8) 1406 (58.4) 463 (13.0)  
Mild to moderate 3317 (13.4)  3103 (13.3) 214 (14.6)  2852 (15.2) 387 (16.1) 78 (2.2)  
Major 4109 (16.6)  3772 (16.2) 337 (23.0)  3387 (18.1) 593 (24.6) 129(3.6)  
Missing 3078 (12.5)  2922 (12.6) 156 (10.6)  171 (0.9) 23 (0.9) 2884 (81.1)  
Major Depression          
No  17373 (70.4)  16455 (70.9) 918 (62.6)  15108 (80.7) 1789 (74.3) 476 (13.4)  
Yes 3964 (16.1)  3597 (15.5) 367 (25.0)  3210 17.1) 577 (23.9) 177 (5.0)  
Missing 3348 (13.6)  3168 (13.6) 180 (12.3)  404 (2.1) 43 (1.8) 2901 (81.6)  
GAD          
No 20714 (83.9)  19610 (84.4) 1104 (75.3)  15517 (82.9) 1868 (77.5) 3329 (93.7)  
Yes 950 (3.8)  849 (3.6) 101 (6.9)  768 (4.1) 148 (6.1) 34 (0.9)  
Missing 3021(12.2)  2761 (11.9) 260 (17.7)  2437 (13.0) 393 (16.3) 191(5.4)  
1
 Smoke daily and who have smoked at least 28 cigarettes in a month 
2 
Including doctoral and licentiate degree 
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Table 2: General information of children of STAGE twins 
 
 Total, N (%)  Asthma in children, N (%)  
   No  Yes  
Age      
0-4.5 6100 (9.2)  5822 (19.1) 278 (12.8)  
>4.5-12 10875 (14.0)  10073 (33.1) 802 (36.9)  
>12-18 8176 (25.1)  7507 (24.7) 669 (30.8)  
>18 7410 (22.8)  6987 (23.0) 423 (19.5)  
Gender      
Boys 15730 (48.3)  14790 (48.7) 940 (43.3)  
Girls 16831 (51.7)  15599 (51.3) 1232 (56.7)  
      
Exposed to parental 
CES-D 
     
No 19759 (60.7)  18423 (60.6) 1336 (61.5)  
Mild to moderate 4154 (12.7)  3859 (12.7) 295 (13.6)  
Major 4758 (14.6)  4444 (14.6) 314 (14.4)  
Missing 3890 (11.9)  3663 (12.0) 227 (10.4)  
Major Depression      
No  23437 (72.0)  21861 (71.9) 1576 (72.5)  
Yes 4887 (15.0)  4528 (14.9) 352 (16.2)  
Missing 4244 (13.0)  4000 (13.2) 244 (11.2)  
GAD      
No 27615 (84.8)  25775 (84.8) 1840 (84.7)  
Yes 1111 (3.4)  1033 (3.4) 78 (3.6)  
Missing 3835 (11.8)  3581 (11.8) 254 (11.7)  
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Table 3: Odds ratios and 95 % confidence intervals for the association between parental anxiety/depression and asthma in STAGE-twins  
     
 Register-based Asthma  Self-reported Asthma  
 Crude OR 
(95% CI) 
Adj * OR 
(95 % CI) 
Adj ^^ OR 
(95 % CI) 
 Crude OR 
 (95% CI) 
Adj  * OR 
 (95 % CI) 
Adj ^^ OR 
 (95 % CI) 
 
CES-D         
No 1.00 1.00 1.00  1.00 1.00 1.00  
Mild to moderate 1.22 (1.04-1.42) 1.25 (1.07-1.47) 1.24 (1.05-1.46)  1.19 (1.05-1.34) 1.17 (1.04-1.32) 1.17 (1.03-1.33)  
Major 1.58 (1.38-1.81) 1.56 (1.36-1.79) 1.42 (1.23-1.64)  1.53 (1.38-1.70) 1.48 (1.33-1.64) 1.42 (1.27-1.58)  
Major Depression         
No  1.00 1.00 1.00  1.00 1.00 1.00  
Yes 1.83 (1.61-2.07) 1.70 (1.49-1.93) 1.56 (1.36-1.79)  1.52 (1.37-1.68) 1.49 (1.35-1.66) 1.44 (1.29-1.61)  
GAD         
No 1.00 1.00 1.00  1.00 1.00 1.00  
Yes 2.11 (1.70-2.62) 1.98 (1.60-2.46) 1.73 (1.37-2.19)  1.60 (1.33-1.92) 1.56 (1.29-1.87) 1.44 (1.18-1.75)  
         
* adjusted for age & gender           
^^ adjusted for age, gender, bmi, educational level, smoking 
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  Table 4: Odds ratios and 95 % confidence intervals for the association between parental anxiety/depression and 
asthma in children of STAGE-twins 
   
 Asthma in children  
 Crude OR 
(95 % CI) 
Adj OR † 
(95 % CI) 
Adj OR¤ 
(95 % CI) 
 
CES-D     
No 1.00 1.00 1.00  
Mild to moderate 1.05 (0.92-1.20) 1.05 (0.92-1.20) 1.03 (0.90-1.18)  
Major 0.97 (0.86-1.11) 0.97 (0.86-1.11) 0.93 (0.81-1.06)  
Major Depression     
No  1.00 1.00 1.00  
Yes 1.08 (0.96-1.21) 1.09 (0.96-1.23) 1.06 (0.94-1.20)  
GAD     
No 1.00 1.00 1.00  
Yes 1.06 (0.84-1.34) 1.07 (0.84-1.35) 0.99 (0.78-1.27)  
     
† adjusted for child age  
¤ adjusted for parental (smoking, gender, educational level, parents own asthma) + child age 
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Table 5:  Co-twin analysis of asthma in STAGE-twins exposed to anxiety and depression 
 
Outcome Register-based asthma (n=530 twin pairs)  Self-reported asthma (n= 666 twin pairs) 
MZ+DZ 
Exposure 
asthma twin 
Crude OR 
  (95% CI) 
Exposure asthma 
twin 
Adj OR *  
 (95 % CI) 
 Exposure 
asthma twin 
Crude OR  
 (95% CI) 
Exposure 
asthma twin 
Adj OR *  
 (95 % CI) 
CES-D 221  190   290  252  
No 83 1.00 74 1.00  105 1.00 91 1.00 
Mild /moderate 60 1.17 (0.85-1.62) 52 1.13 (0.80-1.60)  81 1.09 (0.84-1.42) 70 1.11 (0.84-1.48) 
Major 78 1.32 (0.63-1.58) 64 1.20 (0.87-1.65)  104 1.43 (1.12-1.82) 91 1.44 (1.10-1.89) 
 
         
Major Depression 129  111   187  164  
No 44 1.00 38 1.00  85 1.00 77 1.00 
Yes 85 2.10 (1.54-2.85) 73 1.97 (1.41-2.76)  102 1.28(1.00-1.62) 87 1.20 (0.92-1.56) 
 
         
GAD 36  26   44  36  
No 14 1.00 9 1.00  19 1.00 15 1.00 
Yes 22 1.71 (1.00-2.93) 17 1.67 (0.88-3.22)  25 1.53 (0.95-2.47) 21 1.46 (0.85-2.48) 
MZ 
Exposure 
asthma twin  
Crude OR  
 (95% CI) 
Exposure asthma 
twin  
Adj OR* 
 (95 % CI) 
 Exposure 
asthma twin  
Crude OR 
  (95% CI) 
Exposure 
asthma twin  
Adj OR* 
 (95 % CI) 
CES-D 117  100   146  129  
No 44 1.00 38 1.00  54 1.00 48 1.00 
Mild /moderate 30 1.14 (0.66-1.96) 26 1.05 (0.58-1.88)  44 1.27 (0.81-2.01) 38 1.21 (0.75-1.96) 
Major 43 1.17 (0.74-1.86) 36 1.14 (0.67-1.94)  48 1.28 (0.83-1.98) 43 1.46 (0.90-2.38) 
          
Major Depression 65  54   91  43  
No 23 1.00 19 1.00  45 1.00 21 1.00 
Yes 42 1.83 (1.10-3.04) 35 1.83 (1.02-3.29)  46 1.02 (0.68-1.54) 22 1.01 (0.64-1.60) 
          
DZ 
Exposure 
asthma twin  
Crude OR  
 (95% CI) 
Exposure asthma 
twin  
Adj OR * 
 (95 % CI) 
 Exposure 
asthma   twin 
Crude OR 
  (95% CI) 
Exposure 
asthma twin 
Adj OR * 
  (95 % CI) 
CES-D 104  90   144  123  
No 39 1.00 36 1.00  51 1.00 43 1.00 
Mild /moderate 30 1.15 (0.67-1.97) 26 1.19 (0.64-2.20)  37 1.06 (0.67-1.68) 32 1.14 (0.68-1.91) 
Major 35 1.25 (0.75-2.10) 28 1.10 (0.61-1.97)  56 1.89 (1.20-2.99) 48 2.01 (1.21-3.35) 
          
Major Depression 64  57   96  87  
No 21 1.00 19 1.00  40 1.00 38 1.00 
Yes 43 2.05 (1.21-3.45) 38 1.91 (1.09-3.37)  56 1.40 (0.93-2.10) 49 1.23 (0.80-1.90) 
          
 
* adjusted for bmi, educational level, smoking 
